Abstract
Small cell lung cancer (SCLC) is a distinct and well-reproducible histopathological entity (Hirsch et al. 1982). Besides morphological criteria, SCLC is distinguished from other cell types by ultrastructural, endocrine, cytogenetic, cell-kinetic, and clinical findings (Gropp et al. 1980; Hattori et al. 1972; Whang-Peng et al. 1982). The high labeling index (Muggia et al. 1974; Pettengill et al. 1980) and short doubling time (Straus 1974; Weiss et al. 1970) are manifested clinically by fast growth, rapid onset of signs and symptoms, and a tendency toward early and widespread dissemination (Hansen et al. 1978; Muggia and Chevru 1974). Accordingly, the median survival time from diagnosis without treatment is 2.8 months, with only 4.2% of patients still alive at 1 year (Hyde et al. 1965; Zelen 1973).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abeloff MD, Ettinger DS, Order SE, Khouri N, Mellits ED, Dorschel NT, Baumgardner B (1981) Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lung. Cancer Treat Rep 65: 639–646
Aisner J, Wiernik PH (1980) Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung. Cancer 46: 2543–2549
Aisner J, Whitacre M, Van Echo DA, Wiernik PH (1982) Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. Cancer Treat Rep 66: 221–230
Alberto P, Brunner KW, Martz G, Obrecht JP, Sonntag RW (1976) Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine. Cancer 38: 2208–2216
Aroney RS, Bell DR, Chan WK, Dalley DN, Levi JA (1982) Alternating non-cross-resistant combination chemotherapy for small cell anaplastic carcinoma of the lung. Cancer 49: 2449–2454
Aroney RS, Aisner J, Wesley MN, Whitacre MY, Van Echo DA, Slawson RG, Wiernik PH (1983) Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. Cancer Treat Rep 67: 675–682
Baglan RJ, Marks JE (1981) Comparison of symptomatic and prophylactic irradiation of brain metastases from oat cell carcinoma of the lung. Cancer 47: 41–45
Bakker W, Noordijk EM, Van Oosterom AT (1982) Treatment of small cell lung cancer with combination chemotherapy and radiotherapy: no need for maintenance therapy following the induction of a complete response. Third World Conference on Lung Cancer, Tokyo (Abstr 206 )
Ball ED, Graziano RF, Pettengill OS, Sorenson GD, Fanger NW (1984) Monoclonal antibodies reactive with small cell carcinoma of the lung. JNCI 72: 593–598
Batist G, Ihde DC, Zabell A, Lichter AS, Veach SR, Cohen MH, Carney DN, Bunn PA (1983) Small-cell carcinoma of the lung: reinduction therapy after late relapse. Ann Intern Med 98: 472–474
Bergsagel DE, Jenkin RDT, Pringle JF, White DM, Fetterly JCM, Klaassen DJ, McDermot RSR (1972) Lung cancer. Clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide. Cancer 30: 621–627
Broder LE, Cohen MI-I, Selawry OS (1977) Treatment of bronchogenic carcinoma. II. Small cell. Cancer Treat Rev 4: 219–260
Burdon JGW, Sinclair RA, Henderson MM (1979) Small cell carcinoma of the lung. Prognosis in relation to histologic subtype. Chest 76: 302–304
Burgess RE, Burgess VF, Dibella NJ (1979) Brain metastases in small cell carcinoma of the lung. JAMA 242: 2084–2086
Byhardt RW, Cox JD (1983) Is chest radiotherapy necessary in any or all patients with small cell carcinoma of the lung? Yes. Cancer Treat Rep 67: 209–215
Carney DN, Broder L. Edelstein M, Gazdar AF, Hansen M, Havemann K, Matthews MJ, Sorenson GD, Vindelty L (1983) Experimental studies of the biology of human small cell lung cancer. Cancer Treat Rep 67: 27–35
Can DT, Childs DS Jr, Lee RE (1972) Radiotherapy plus 5-FU compared to radiotherapy alone for inoperable and unresectable bronchogenic carcinoma. Cancer 29: 375–380
Catane R, Lichter A, Lee YJ, Brereton HD, Schwade JD, Glatstein E (1981) Small cell lung cancer: analysis of treatment factors contributing to prolonged survival. Cancer 48: 1936–1943
Cohen MH (1983) Is thoracic radiation therapy necessary for patients with limited-stage small cell lung cancer? No. Cancer Treat Rep 67: 217–221
Cohen MH, Ihde DC, Bunn PA Jr, Fossieck BE Jr, Matthews MJ, Shackney SE, Johnston-Early A, Makuch R, Minna JD (1979) Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep 63: 163–170
Comis R, Meyer J, Ginsberg S, Issell B, Gullo J, DiFino S, Tinsley R, Poiesz B, Rudolph A (1982) The current results of chemotherapy (CTH) plus adjuvant surgery (AS) in limited small cell anaplastic lung cancer (SCALC). Proc Am Soc Clin Oncol 1: 147 (Abstr C-571)
Cullen MH (1982) Maintenance chemotherapy for small cell lung cancer: is it necessary? Third World Conference on Lung Cancer, Tokyo (Abstr 241 )
Cuttitta F, Rosen S, Gazdar AF, Minna JD (1981) Monoclonal antibodies that demonstrate specificity for several types of human lung cancer. Proc Natl Acad Sci USA 78: 4591–4595
Eagan RT, Lee RE, Frytak S, Ingle JN, Creagan ET (1980) Combination chemotherapy (CCT) with and without cis-diamminedichloroplatinum(II) plus thoracic radiation therapy (TRT) for limited small cell lung cancer (SCLC). Proc Am Assoc Cancer Res 21: 131 (Abstr 523)
Ettinger DS, Lagakos S (1982) Phase III study of CCNU, cyclophosphamide, adriamycin, vincristine, and VP-16 in small-cell carcinoma of the lung. Cancer 49: 1544–1554
Fox RM, Woods RL, Brodie GN, Tattersall MHN (1980) A randomized study: small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 6: 1083–1085
Gatzemeier U (1983) Mehrjährige Verlaufsbeobachtung and Ergebnisse nach Chemotherapie (ACO) des kleinzelligen Bronchialkarzinoms. Prax Klin Pneumol 37: 144–147
Ginsberg RJ, Shepherd FA, Evans WK, Feld R, Cooper JD, Ilves R, Todd TRJ, Pearson FG, Waters PF, Baker MA (1983) Chemotherapy followed by adjuvant surgery in the treatment of limited small cell carcinoma (SCLC). 13th International Congress of Chemotherapy, Vienna. Proceedings, part 228, pp 14–18
Goldie JH, Coldman AJ, Gudauskas GA (1982) Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66: 439–449
Greco FA, Einhorn LH, Hande KR, Oldham RK (1979) Phase II studies in resistant small cell lung cancer. Proc Am Assoc Cancer Res Am Soc Clin Oncol 20: 28
Green RA, Humphrey E, Close H, Patino ME (1969) Alkylating agents in bronchogenic carcinoma. Am J Med 46: 516–525
Gropp C, Havemann K, Scheuer A (1980) Ectopic hormones in lung cancer patients at diagnosis and during therapy. Cancer 46: 347–354
Hande KR, Oldham RK, Fer MF, Richardson RL, Greco FA (1982) Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer. Am J Med 73: 413–419
Hansen HH, Dombernowsky P, Hirsch FR (1978) Staging procedures and prognostic features in small cell anaplastic bronchogenic carcinoma. Semin Oncol 5: 280–287
Hansen HH, Dombernowsky P, Hansen HS, Rörth M (1979) Chemotherapy versus chemotherapy plus radiotherapy in regional small-cell carcinoma of the lung. A randomized trial. Proc Am Assoc Cancer Res 20: 277 (Abstr 1124)
Hansen HH, Dombernowsky P, Hirsch FR, Hansen M, Rygârd J (1980) Prophylactic irradiation in bronchogenic small cell anaptastic carcinoma. A comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy. Cancer 46: 279–284
Harper PG, Daily MB, Geddes DM, Spiro SG, Smyth JF, Souhami RL (1982) Epipodophyllotoxin (VP 16–213) in small cell carcinoma of the bronchus resistant to initial combination chemotherapy. Cancer Chemother Pharmacol 7: 179–180
Hattori S, Matsuda M, Tateishi R, Nishihara H, Horai T (1972) Oat-cell carcinoma of the lung. Clinical and morphological studies in relation to its histogenesis. Cancer 30: 1014–1024
Higgins GA (1972) Use of chemotherapy as an adjuvant to surgery for bronchogenic carcinoma. Cancer 30: 1383–1387
Hirsch FR, Matthews MJ, Yesner R (1982) Histopathologic classification of small cell carcinoma of the lung. Comments based on an interobserver examination. Cancer 50: 1360–1366
Hirsch FR, Osterlind K, Hansen HH (1983) The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. A study of 375 consecutive patients. Cancer 52: 2144–2150
Host H (1973) Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma. Cancer Chemother Rep Pt 3, 4 (2): 161–164
Hyde L, Yee J, Wilson R, Patno ME (1965) Cell type and the natural history of lung cancer. JAMA 193: 52–54
Ihde DC, Cohen MH, Bernath AM, Matthews MJ, Bunn PA, Minna JD (1978) Serial fiberoptic bronchoscopy during chemotherapy for small cell carcinoma of the lung. Chest 74: 531–536
Issell B, Rudolph A, Lawson R, Maroun J, Comis R. Hong W, Speer J, Luedke D, Lanzotti V, Hurtubise M, Broder L, Rosenbaum P, White M (1983) The substitution of etoposide for doxorubicin in small cell lung cancer combination chemotherapy. 13th International Congress of Chemotherapy, Vienna, Proceedings, part 248, pp 15–19
Jackson DV, Richards II F, Cooper R, Ferree C, Muss HB, White DR, Spur CL (1977) Prophylactic cranial irradiation in small cell carcinoma of the lung. A randomized study. JAMA 237: 2730–2733
Johnson RE, Brereton HD, Kent CH (1976) Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure. Lancet 2: 289–291
Karrer K, Denck H, Pridun N, Zwintz E, Coop. Group (1983) Combination of early surgery for cure and polychemotherapy in small-cell bronchial carcinoma. 13th International Congress of Chemotherapy, Vienna. Proceedings, Addendum, part 228 /52
Kessinger A, Foley JF, Lemon HM (1983) Therapeutic management of small cell lung cancer. Fewer toxic reactions with lower chemotherapeutic drug dosages. JAMA 250: 3188–3191
Komaki R, Cox JD, Whitson W (1981) Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Rep 65: 811–814
Krauss S, Perez C (1980) Treatment of localized undifferentiated small cell lung carcinoma (SCLC) with radiation therapy (RT) with or without combination chemotherapy (CT) with cyclophosphamide (DTIC). In: Hansen HH, Dombernowsky P (eds) Abstracts of the 2nd world conference on lung cancer. Excerpta Medica, Amsterdam, p 157
Livingston RB, Moore TN, Heilbrun L, Bottomley R, Lehane D, Rivkin SE, Thigpen T (1978) Small-cell carcinoma of the lung: combined chemotherapy and radiation. A Southwest Oncology Group study. Ann Intern Med 88: 194–199
Lowenbraun S, Bartolucci A, Smalley RV, Lynn M, Krauss S, Durant JD, Southeastern Cancer Study Group (1979) The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma. Cancer 44: 406–413
Mason BA, Richter MP, Catalono RB, Creech RB (1982) Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma-A pilot study. Cancer Treat Rep 66: 1609–1612
Matthews MJ (1983) Small cell carcinoma of the lung influence of cell subtype in response to therapy. 13th International Congress of Chemotherapy, Vienna. Proceedings, part 228, pp 1–7
Matthews MJ, Rozencweig M, Staquet MJ, Minna JD, Muggia FM (1980) Long-term survivors with small cell carcinoma of the lung. Eur J Cancer 16: 527–531
Maurer LH, Tulloh M, Weiss RB, Blom J, Leone L, Glidewell O, Pajak TF (1980) A randomized combined modality trial in small cell carcinoma of the lung: comparison of combinationchemohterapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation. Cancer 45: 30–39
McCracken JD, Chen T, White J, Samson M, Stephens R, Coltman CA, Saiki J, Lane M, Bonnet J, McGavran M (1982) Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung. A Southwest Oncology Group study. Cancer 49: 2252–2258
McMahon LD, Herman TS, Manning MR, Dean JC (1979) Patterns of relapse in patients with small cell carcinoma of the lung treated with adriamycin-cyclophosphamide chemotherapy and radiation therapy. Cancer Treat Rep 63: 359–362
Medical Research Council (1979) Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Br J Cancer 40: 1–10
Medical Research Council Lung Cancer Working Party (1981) Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung: the results at 36 months. Br J Cancer 44: 611–617
Mercke C, Arvastsson B, Ewers B, Hâkansson L, Kjellen E, Landberg T, Svensson G (1980) Cy clophosphamide, doxorubicin and vincristine combined with radiotherapy in small cell cancer of the bronchus (SBC). In: Hanssen HH, Dombernowsky P (eds) Abstracts of the 2nd world conference on lung cancer. Excerpta Medica, Amsterdam, p 159
Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results in cancer treatment. Cancer 47: 207–214
Mountain CF (1974) Surgical therapy in lung cancer: Biologic, physiologic, and technical determinants. Semin Oncol 1: 253–258
Muggia FM, Krezoski SK, Hansen HH (1974) Cell kinetic studies in patients with small cell carcinoma of the lung. Cancer 34: 1683–1690
Muggia FM, Chervu LR (1974) Lung cancer: diagnosis in metastatic sites. Semin Oncol 1: 217–228
Murray N, Klimo P, Goldie J, Hadzic E, Fryer C. Voss N, Gudauskas G (1982) Alternating combination chemotherapy for small cell carcinoma of the lung (SCCL). Proc Am Soc Clin Oncol 1: 151 (Abstr C-587)
Nakhosteen JA, Niederle N (1983) Small cell lung cancer. Serial bronchofiberscopy and photographic documentation — the bridge sign. Chest 83: 12–16
Niederle N (1983) Neue Ansätze in der Diagnostik and Therapie des kleinzelligen Bronchialkarzinoms. Habilitationsschrift, University of Essen
Niederle N, Krischke W, Bremer K, Schmidt CG, Seeber S (1982a) Small-cell bronchogenic carcinoma — primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU. Cancer Treat Rev (Suppl A) 9: 101–105
Niederle N, Krischke W, Schulz U, Schmidt CG, Seeber S (1982b) Untersuchungen zur kurzzeitigen Induktions-and zyklischen Erhaltungstherapie beim inoperablen kleinzelligen Bronchialkarzinom. Klin Wochenschr 60: 829–838
Niederle N, Schütte J, Schmidt CG, Seeber S (1984) Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin. Cancer Treat Rep 68: 791–792
Osoba D, Evans WK, Feld R (1981) VP-16 and cis-platinum (P) combination chemotherapy for relapse in small cell lung cancer (SCLC). Proc Am Assoc Cancer Res Am Soc Clin Oncol 22: 495 (Abstr C-633)
Osterlind K, Sörenson S, Hansen HH, Dombernowsky P, Hirsch FR, Hansen M, Rerth M (1983) Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung. Cancer Res 43: 6085–6089
Peschel PE, Kapp DS, Carter D, Knwolton A (1981) Long term survivors with small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 7: 1545–1548
Petrovich Z, Mietlowski W, Ohanian M, Cox J (1977) Clinical report on the treatment of locally advanced lung cancer. Cancer 40: 72–77
Pettengill OS, Sorenson GD, Wurster-Hill DH, Curphey TJ, Noll WW, Cate CC, Maurer LH (1980) Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer 45: 906–918
Poplin EA, Aisner J. Van Echo DA, Whitacre M, Wiernik PH (1982) CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma. Cancer Treat Rep 66: 1557–1559
Radice PA, Matthews MJ, Ihde DC, Gazdar AF, Carney DN, Bunn PA, Cohen MH, Fossieck BE, Makuch RW, Minna JD (1982) The clinical behavior of “mixed” small cell/large cell bronchogenic carcinoma compared to “pure” small cell subtypes. Cancer 50: 2894–2902
Rosen ST, Makuch RW, Ihde DC, Matthews MJ, Minna JD, Glatstein E, Bunn PA Jr (1983) Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer. Am J Med 74: 615–624
Rosenman J, Choi ND (1982) Improved quality of life of patients with small-cell carcinoma of the lung by elective irradiation of the brain. Int J Radiat Oncol Biol Phys 8: 1041–1043
Roszkowski K, Pawlicki M, Slupek A, Traczyk K, Wiatr E, Zych J, Rowinska-Zakrzewska E (1983) VP-16–213 and adriamycin in second line chemotherapy of small cell lung cancer. 13th International Congress of Chemotherapy, Vienna. Proceedings, part 248, pp 47–50
Saugier B, Brunat M, Cordier JF, Gerard JP, Dorsit G, Marchandise JF, Bastidon R, Perol M, Brune J, Galy P (1978) Cancer pulmonaire â “petites cellules”. Résultats de l’association adriamycine-vincristine-cyclophosphamide chez 37 patients. Nouv Presse Méd 7: 1357–1361
Schütte J, Niederle N, Krischke W, Seeber S, Schmidt CG (1984) Sequential alternating combination chemotherapy ± radiotherapy in small cell lung cancer (SCLC). Proc Am Assoc Cancer Res 25: 177 (Abstr. 702)
Seeber S, Niederle N, Schilcher RB, Schmidt CG (1980) Adriamycin, Cyclophosphamid and Vincristin (“ACO”) beim kleinzelligen Bronchialkarzinom. Verlaufsanalyse and Langzeitergebnisse. Onkologie 3: 5–11
Seydel HG, Creech R, Pagano M, Salazar O, Rubin P, Concannon J, Carbone P, Mohuiddin M, Perez C, Matthews M (1983) Combined modality treatment of regional small cell undifferentiated carcinoma of the lung: a cooperative study of the RTOG and ECOG. Int J Radiat Oncol Biol Phys 9: 1135–1141
Shank B, Natale RB, Hilaris BS, Wittes RE (1981) Treatment of small cell carcinoma of lung with combined high dose mediastinal irradiation, whole brain prophylaxis and chemotherapy. Int J Radiat Oncol Biol Phys 7: 469–475
Shields TW, Higgins GA Jr, Matthews MJ, Keehn RJ (1982a) Surgical resection in the management of small cell carcinoma of the lung. J Thorax Cardiovasc Surg 84: 481–488
Shields TW, Matthews MJ, Higgins GA (1982b) Long term adjuvant chemotherapy in patients after resection of carcinoma of the lung. Third World Conference on Lung Cancer. Tokyo, p 96 (Abstr 117)
Sierocki JS, Hilaris BS, Hopfan S, Martini N, Barton D, Golbey RB, Wittes RE (1979) cis-Dichlorodiammineplatinum(II) and VP-16–213: an active induction regimen for small cell carcinoma of the lung. Cancer Treat Rep 63: 1593–1597
Sierocki JS, Hilaris BS, Hopfan S, Golbey RB, Wittes RE (1980) Small cell carcinoma of the lung. Experience with a six-drug regimen. Cancer 45: 417–422
Smith IE, Sappino AP, Bondy PK, Gilby ED (1981) Long-term survival five years or more after combination chemotherapy and radiotherapy for small cell lung carcinoma. Eur J Cancer Clin Oncol 17: 1249–1253
Sörenson S (1983) Bronchoscopic findings in patients with a complete radiographic regression of small cell bronchogenic carcinoma. Eur J Cancer Clin Oncol 19: 589–595
Souhami RL, Spiro SG, Tobias JS, Geddes DM (1982) Combination chemotherapy and radiotherapy in small cell carcinoma of the bronchus. 3rd World conference on lung cancer, Tokyo (Abstr 213 )
Stevens E, Einhorn L, Rohn R (1979) Treatment of limited small cell lung cancer. Proc Am Assoc Cancer Res Am Soc Clin Oncol 20: 435 (Abstr C-599)
Strauchen JA, Egbert BM, Kosek JC, Mackintosh R, Misfeldt DS (1983) Morphologic and clinical determinants of response to therapy in small cell carcinoma of the lung. Cancer 52: 1088–1092
Straus MJ (1974) The growth characteristics of lung cancer and its application to treatment design. Semin Oncol 1: 167–174
Thatcher N, Hunter RD, Jegarajah S, Barber PV, Carroll KB, Wilkinson PM, Crowther D (1982) 11-Week course of sequential methotrexate, thoracic irradiation, and moderate-dose cyclophosphamide for “limited”-stage small-cell bronchogenic carcinoma. A study from the Manchester Lung Tumour Group. Lancet 1: 1040–1043
Valdivieso M, McMurtrey MJ, Farha P, Frazier OH, Barkley HT, Paone JF, Spitzer G, Mountain CF (1982) Increasing importance of adjuvant surgery in the therapy of patients with small cell lung cancer (SCLC). Proc Am Soc Clin Oncol l: 148 (Abstr C-576)
van Houtte P, Tancini G, de Jager R, Lustman-Maréchal J, Milani F, Bonadonna G, Kenis Y (1979) Small cell carcinoma of the lung: a combined modality treatment. Eur J Cancer 15: 1159–1165
Vermorken JB, Stam J, Van Zandwijk N, Roozendaal KJ, McVie JG, Pinedo HM (1982) Alternating chemotherapy in small cell lung cancer (SCLC). Proc Am Soc Clin Oncol 1: 149 (Abstr C-580)
Vincent RG, Wilson HE, Lane WW, Chen TY, Raza S, Gutierrez AC, Caracandas JE (1981) Progress in the chemotherapy of small cell carcinoma of the lung. Cancer 47: 229–235
Weiss W, Boucot KR, Cooper DA (1970) The histopathology of bronchogenic carcinoma and its relation to growth rate, metastasis, and prognosis. Cancer 26: 965–970
Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF, Minna JD (1982) Specific chromosome defect associated with human small-cell lung cancer: deletion 3p(14–23). Science 215: 181–182
Wolf J, Patno ME, Roswit B, D’Esopo N (1966) Controlled study of survival of patients with clinically inoperable lung cancer treated with radiation therapy. Am J Med 40: 360–367
Woods RL, Levi JA (1983) Cis-platinum and VP16–213 treatment of small cell lung cancer (SCLC) — a randomised study of duration of therapy. Third World Conference on Lung Cancer. Tokyo (Abstr 217 )
Young JA, Dittman RO, Seagren SL, Taetle R, Rentschler RE, Lea JW Jr, Lehar TJ, Green MR, Stanton W, Mendelsohn J, Royston I (1982) Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung. Cancer Treat Rep 66: 1399–1401
Zelen M (1973) Keynote address on biostatistics and data retrieval. Cancer Chemother Rep Pt. 3, 4 (2): 31–42
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Niederle, N., Schütte, J. (1985). Chemotherapeutic Results in Small Cell Lung Cancer. In: Seeber, S. (eds) Small Cell Lung Cancer. Recent Results in Cancer Research, vol 97. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82372-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-82372-5_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82374-9
Online ISBN: 978-3-642-82372-5
eBook Packages: Springer Book Archive